NCT04941833View on ClinicalTrials.gov

Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

July 31, 2022

Study Completion Date

September 30, 2022

Conditions
Endometrioma
Interventions
DRUG

Desogestrel Oral Tablet

Cerazette is the brand name of the desogestrel which contain of 0.075 mg of desogestrel

Trial Locations (1)

10400

Rajavithi Hospital, Bangkok

All Listed Sponsors
lead

Department of Medical Services Ministry of Public Health of Thailand

OTHER_GOV